Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 2, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	3,337	3,371	3,572	4,057	1,849	465
Market Cap Growth	-15.14%	-5.63%	-11.97%	119.38%	297.73%	-72.45%
Enterprise Value	4,691	3,993	4,419	4,511	2,181	731
Last Close Price	710.05	716.65	775.92	913.14	461.77	115.78
PE Ratio	17.60	21.58	33.05	64.04	91.80	24.45
PS Ratio	0.82	0.97	1.30	1.81	1.38	0.41
PB Ratio	2.55	2.78	3.71	5.96	4.29	1.13
P/TBV Ratio	2.56	2.79	3.72	5.97	4.30	1.13
P/OCF Ratio	-	-	-	-	1088.52	-
EV/Sales Ratio	1.16	1.15	1.61	2.01	1.63	0.65
EV/EBITDA Ratio	9.70	10.50	15.82	32.51	23.72	8.64
EV/EBIT Ratio	10.69	11.64	17.56	38.42	30.24	11.09
Debt / Equity Ratio	1.05	0.87	0.90	0.89	1.06	0.96
Debt / EBITDA Ratio	2.84	2.77	3.10	4.37	4.99	4.71
Asset Turnover	-	1.23	1.24	1.29	0.88	0.92
Inventory Turnover	-	1.70	2.23	3.23	1.81	1.91
Quick Ratio	-	0.40	0.27	1.25	0.49	0.49
Current Ratio	-	1.54	1.55	2.07	1.51	1.27
Return on Equity (ROE)	-	14.34%	13.14%	11.40%	4.78%	4.74%
Return on Assets (ROA)	-	7.59%	7.08%	4.21%	2.97%	3.35%
Return on Capital (ROIC)	-	10.46%	10.09%	6.74%	5.30%	5.65%
Return on Capital Employed (ROCE)	-	24.40%	21.40%	10.40%	9.60%	11.90%
Earnings Yield	5.63%	4.63%	3.03%	1.56%	1.09%	4.09%
FCF Yield	-	-2.40%	-6.69%	-1.64%	-0.66%	-26.10%
Dividend Yield	0.10%	0.10%	0.09%	0.08%	0.15%	0.57%
Buyback Yield / Dilution	-0.86%	-3.66%	-7.85%	-4.06%	-0.01%	-3.67%
Total Shareholder Return	-0.76%	-3.56%	-7.76%	-3.98%	0.14%	-3.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.